Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease. [electronic resource]
Producer: 20110602Description: 323-31 p. digitalISSN:- 1873-4995
- Animals
- Antibodies, Monoclonal -- chemistry
- Antigens, Tumor-Associated, Carbohydrate -- metabolism
- Cell Line
- Drug Carriers -- chemistry
- Endothelial Cells -- immunology
- Endothelium, Vascular -- cytology
- Enzyme Replacement Therapy
- Fabry Disease -- drug therapy
- Humans
- Intercellular Adhesion Molecule-1 -- immunology
- Lysosomes -- metabolism
- Mice
- Mice, Inbred C57BL
- alpha-Galactosidase -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.